Speaker illustration

Professor Peter Van Der Meer

University Medical Centre Groningen, Groningen (Netherlands (The))

Member of:

European Society of Cardiology
Heart Failure Association

Peter van der Meer is a cardiologist, chair of the Department of Experimental Cardiology and professor of Heart Failure and Translational Cardiology at the University of Groningen. Professor van der Meer received both his MD and PhD cum laude and completed a postdoctoral fellowship at Harvard Medical School, Boston, MA, USA. He authored >300 manuscripts, has an H-index of 77 and was member of the 2022 ESC CardioOncology guidelines and is member of the ESC/HFA working group on PeriPartum CardioMyopathy. He is a member of several steering committees of large phase 3 trials. His research is funded by national and international grants including an ERC CoG grant. His research group consists of PhD students and post-docs with various backgrounds (biologists, medical doctors and biomedical-engineers) working on translational research topics. His research focusses on understanding the susceptibility to develop heart failure and on exploring novel treatment targets and therapies.

Implementation of heart failure therapy: different approaches in the Netherlands and Norway

Event: ESC Congress 2023

Topic: Chronic Heart Failure

Session type: Global Community

Thumbnail

Diagnosing cardiac amyloidosis - a puzzling case study

Event: ESC Congress 2023

Topic: Cardiac Amyloidosis

Session type: Satellite Symposium

Thumbnail

Cardiovascular disease in special populations 2

Event: Heart Failure 2023

Topic: Cardio-Oncology

Session type: Clinical Cases

Thumbnail

Cardio-oncology 3

Event: ESC Congress 2022

Topic: Cardio-Oncology

Session type: Moderated ePosters

Thumbnail

Cardio-oncology 1

Event: ESC Congress 2022

Topic: Cardio-Oncology

Session type: Moderated ePosters

Thumbnail

Clinical case discussion: the value of optimising RAAS inhibition and preserving normokalemia in heart failure

Event: ESC Congress 2022

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session type: Satellite Symposium

Thumbnail

Changing the outlook for a chronic heart failure patient: Optimising RAASi treatment through long-term potassium control

Event: ESC Congress 2020

Topic: Treatment

Session type: Industry Q&A session

Thumbnail

Rapid Fire 3 - Acute heart failure

Event: Heart Failure 2019

Topic: Other

Session type: Rapid Fire Abstracts

Thumbnail

Diagnostics and continuous monitoring for prevention of heart failure deterioration: a new multi-sensor approach and considerations for the patient care pathway

Event: Heart Failure 2018

Topic: Diagnostic Methods, Other

Session type: Satellite Symposium

Thumbnail

Iron deficiency: an important comorbidity

Event: Heart Failure 2018

Topic: Comorbidities

Session type: Satellite Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb